Pharmaceutical

ESC 2024: Beta blocker treatment paradigm shifts for myocardial infarction

New data provides more evidence on choosing the ideal approach for prescription of beta blockers for myocardial infarction.

Sep 4, 2024 - 04:00
ESC 2024: Beta blocker treatment paradigm shifts for myocardial infarction
New data provides more evidence on choosing the ideal approach for prescription of beta blockers for myocardial infarction.
Read the original article

Tags:

Previous Article

Syntekabio and Enamine partner for AI-based drug development

Next Article

UAE MoHAP and Novo Nordisk partner for obesity management

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: Scientists inch closer to single-shot gene editing cure for blood disorders

STAT+: Scientists inch closer to single-shot gene editi...

Jul 28, 2023

New research underscores benefits of gender-affirming hormones, rebutting anti-trans claims

New research underscores benefits of gender-affirming h...

Jun 24, 2023

Here are the 10 drugs that will be up first for Medicare price negotiation

Here are the 10 drugs that will be up first for Medicar...

Aug 29, 2023